Infant formula hard copy record-keeping should be kept to a minimum, USF&P maintains.
This article was originally published in The Tan Sheet
Executive Summary
INFANT FORMULA HARD COPY RECORD-KEEPING SHOULD BE MINIMIZED, USF&P SAYS in Dec. 17 comments to FDA on the agency's proposed revision to infant formula current Good Manufacturing Practices regulations. U.S. Foods & Pharmaceuticals, a formulator, private label manufacturer and marketer based in Madison, Wisc., says with regard to record-keeping that "hard copy recording should be reduced to a minimum and attempts made to ensure that all key process results are obtained electronically."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning